project id: TCGA-UVM; case submitter id: TCGA-WC-A87U; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.2; age at index: 73; days to birth: -26933; days to death: 1581; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2011; age at diagnosis: 26933; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8774/3; primary diagnosis: Spindle cell melanoma, type B; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: Not Reported; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2199; days to sample procurement: 0; initial weight: 20.0; portion submitter id: TCGA-WC-A87U-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0;